Creative BioMart to Present at
                        BIO-Europe Spring Creative BioMart to Join NIH Research Festival Biotech Vendor Exhibits 2024 | Sep. 25th, 2024

Recombinant Human MFGE8 Protein (Met1-Lys239, Trp137-Cys387), C-His tagged

Cat.No. : MFGE8-4542H
Product Overview : Recombinant human MFGE8 (Met1-Lys239, Trp137-Cys387) fused with the C-terminal His tag was expressed in E. coli.
  • Specification
  • Gene Information
  • Related Products
  • Download
Source : E. coli
Species : Human
Tag : His
Form : Lyophilized powder/frozen liquid
Molecular Mass : 54.9 kDa
Protein length : Met1-Lys239, Trp137-Cys387
Purity : >90% as determined by SDS-PAGE.
Notes : For research use only.
Storage : Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8 centigrade for one week. Store at -20 to -80 centigrade for twelve months from the date of receipt.
Storage Buffer : Supplied as solution form in PBS, pH 7.5 or lyophilized from PBS, pH 7.5.
Reconstitution : Reconstitute in sterile water for a stock solution.
Shipping : They are shipped out with dry ice/blue ice unless customers require otherwise.
Gene Name : MFGE8 milk fat globule-EGF factor 8 protein [ Homo sapiens (human) ]
Official Symbol : MFGE8
Synonyms : MFGE8; milk fat globule-EGF factor 8 protein; SPAG10, sperm associated antigen 10; lactadherin; BA46; EDIL1; hP47; HsT19888; MFG E8; OAcGD3S; SED1; sperm surface protein hP47; medin; sperm associated antigen 10; breast epithelial antigen BA46; O-acetyl disialoganglioside synthase; HMFG; MFGM; MFG-E8; SPAG10;
Gene ID : 4240
mRNA Refseq : NM_001114614
Protein Refseq : NP_001108086
MIM : 602281
UniProt ID : Q08431

For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.

Inquiry

  • Reviews
  • Q&As

Customer Reviews (3)

Write a review
Reviews
08/08/2022

    It has high application effect and safety in clinical treatment.

    10/08/2021

      MFGE8 has a high resolution in Western blots, which can distinguish similar protein molecular weights.

      11/09/2020

        Good stability and activity retention during long-term storage.

        Q&As (6)

        Ask a question
        Is there a relationship between MFGE8's structure and function? 01/13/2023

        The structure of MFGE8 determines its ability and stability to bind to other proteins. The study of its structure can help us understand its function and mechanism of action.

        Does MFGE8 interact with other proteins? 11/16/2022

        MFGE8 can interact with a variety of other proteins, including Caspase-3, Caspase-8, EGFR, etc. These interactions enable it to regulate processes such as apoptosis, signal transduction, and cell adhesion.

        What will future research on MFGE8 focus on? 05/18/2022

        Future studies of MFGE8 may focus on the following aspects: its structure-function relationship, mechanisms of interaction with other proteins, regulatory mechanisms in cells, and potential therapeutic applications. At the same time, the study of MFGE8's interaction with specific signal transduction pathways and its regulatory effect on cell growth and differentiation will also become one of the future research priorities.

        What are the treatment strategies for MFGE8? 07/29/2021

        Therapeutic strategies for MFGE8 may include regulating its expression level, inhibiting its interaction with other proteins, and promoting or inhibiting its function. These methods may have potential applications in the treatment of cancer, neurodegenerative diseases, and autoimmune diseases.

        Does MFGE8 have a role in neurodegenerative diseases? 07/07/2021

        In neurodegenerative diseases, MFGE8 may influence the survival and death processes of neurons by regulating apoptosis and signal transduction. It could be a potential target for the treatment of neurodegenerative diseases.

        What factors should be considered in drug development for MFGE8? 08/25/2020

        Drug development against MFGE8 needs to consider its specificity, safety, pharmacokinetic properties, and potential side effects. In addition, issues such as the dosage form, route of administration and design of clinical trials need to be considered.

        Ask a Question for All MFGE8 Products

        Required fields are marked with *

        My Review for All MFGE8 Products

        Required fields are marked with *

        0

        Inquiry Basket

        cartIcon
        logo

        FOLLOW US

        Terms and Conditions        Privacy Policy

        Copyright © 2024 Creative BioMart. All Rights Reserved.

        Contact Us

        • /
        • Service lnquiry:

        Stay Updated on the Latest Bioscience Trends